If you're in London before January 6th 2008, the Animal's War exhibition at the Imperial War Museum might be worth a visit. Sponsored by The Kennel Club and PetPartners, the family exhibition explores the remarkable role of animals in conflict from the First World War to the present day using hands-on interactives, photographs, film and sound clips, paintings, touchable sculptures, and memorabilia from the Imperial War Museum collections and private and public lenders from all over the world.
Graham Gardner has launched its summer collection of scrubwear in the form updated versions of its Urbane and Easiphit Collections, with new colour combinations added to the range.
The Urbane Collection, pictured right, is designed specifically for the female form. Easiephit is a contempary unisex collection.
Simon Ward, Sales Director said: "Scrubwear is becoming a firm favourite with veterinary staff in the UK. The relaxed comfort offered by scrubs is very attractive to staff, and the smart image of colour coded garments is very well received by managers seeking a unified department look. With the increased stocks and increased colour combinations, customers can now get their hands on the new uniforms more quickly than ever before!"
Other colour combinations are still available as special imports. Non-stocked colour requests will be directed to Grahame Gardner's USA Partners and the sales team will ensure that customers are kept updated as to delivery times.
Both Easiephitt and Urbane have also increased their stocked size range. Grahame Gardner now aim to hold sizes from extra, extra small to extra, extra large.
For further information on Urbane, Easiephitt or Grahame Gardner Ltd, please call 0116 255 6326, or visit http://www.grahamegardner.co.uk/.
Vets Now has this month launched a new fast track programme called 'Cutting Edge', which the company says is aimed at young, dynamic vets.
The 'Cutting Edge' initiative is apparently the first training programme of its kind in the UK and will see 40 graduates who graduated between 2006 and 2009 recruited into a 10 week fast track training programme, before they take up permanent positions in Vets Now clinics. Each recruit will get a salary package which will put them on £40k within 24 months.
Interviews and selection will be held mid-late August at a number of selection centres across the UK, with the first intake of 20 recruits commencing their fast track training programme on 4 October and taking up their positions in a Vets Now clinic in December.
A second intake of recruits to the programme will be selected during November, with these recruits taking up their positions on the fast track training late in January.
The programme is being spearheaded by Vets Now Clinical Director and experienced clinician and teacher in Emergency and Critical Care, Amanda Boag, MA VETMB DipACVIM DACVECC FHEA MRCVS who said: "This is a unique and hugely exciting opportunity for recently qualified vets to enter the field of Emergency and Critical Care. We're looking for dynamic and energetic young vets with a real passion for continuing their clinical development who feel they have what it takes to succeed in this exciting, and growing sector of veterinary medicine."
She added: "The recruits who we select will embark upon an intensive period of training over the 10 week period which will give them the necessary skills and knowledge to launch their career in ECC. They will also receive ongoing support during their first two years as a veterinary surgeon in a Vets Now clinic with a very generous CPD allowance. The initial 10 week period will be a combination of lectures and interactive seminars, practical training in our clinical skills laboratory and mentored work in our clinics. Developing clinical expertise and problem solving skills will clearly be the most significant component of the training but there will also be support and training in other vital skills including communication."
Until now, Vets Now would only employ veterinary surgeons with at least two years post-qualified small animal experience or who have completed their PDP. This new programme has been launched to attract and support young talent in making the move to this growing sector of veterinary medicine.
Recent graduates who are interested in developing a career in ECC are invited to apply in the first instance by contacting the Vets Now recruitment team on 01383 841181 or by emailing cuttingedge@vets-now.com.
The new initiative also has a Facebook page - www.facebook.com/vetsnowcutting edge and you can follow news and updates on the 'Cutting Edge' Twitter page at www.twitter.com/vncuttingedge.
The RCVS has appointed Amanda Boag as its new Treasurer, replacing Dr Bradley Viner who will become (junior) Vice-President in July.
Amanda will officially take up her post at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 11 July.
Amanda is a Clinical Director at Vets Now and is also currently President of the European Society of Veterinary Emergency and Critical Care. She was elected to RCVS Council for a four-year term in 2012.
As Treasurer she will be responsible for maintaining an overview of the College's affairs, ensuring its financial viability and making sure that proper financial records and procedures are maintained.
Amanda said: "I am very honoured to have been appointed Treasurer for the RCVS and am looking forward to working closely with other Council members and the Belgravia House team.
"I would particularly like to thank my predecessor Bradley Viner for the excellent work he has done over the past four years. This has been a period of great change for the College and during his tenure he has done a huge amount of work to support the improvements in governance, including standardising the way that the College's accounts are reported.
"Our finances are currently in a healthy state despite no increase in the annual renewal fee for several years. I am now looking forward to building on his legacy and ensuring the finances remain healthy, allowing us to move forward with our Strategic Plan."
At RCVS Day on 11 July, Professor Stuart Reid will also be confirmed as President; current President Neil Smith as (senior) Vice-President; Chris Tufnell as Chairman of the Education Committee; and David Catlow as Chairman of the Standards Committee.
Merial has joined forces with the Global Alliance for Rabies Control (GARC) promote its "Me and My Dog - Together Against Rabies" social media campaign, designed to raise awareness of the importance of vaccinating dogs against rabies.
As part of the campaign, pet owners are asked to share photos of themselves with their dog on social media channels, using the hash tags #TogetherAgainstRabies and #MerialMeAndMyDog.
Merial says the increased numbers of pets travelling since the changes to the Pet Travel Scheme rules in 2012 means that awareness of rabies amongst pet owners is important, despite the fact that the disease is not endemic in the UK.
Joanne Maki, Director Veterinary Public Health for Wildlife and Companion Animals for Merial said: "The "Me and My Dog - Together against Rabies" campaign is a unique opportunity for all of us to play a part in spreading the word about eliminating human rabies through the vaccination of animals. The more of us who participate, the stronger we are in this important fight".
Intervet/Schering-Plough Animal Health has produced a new Orf Vaccination Starter Pack to help vets better inform their sheep farmer clients about the disease.
The new campaign Vaccination Starter Pack includes a practical guide to Orf and its control in UK sheep flocks, a DVD profiling vet and farmer experiences of managing the disease, an 'Orf questions answered' handout and a best practice vaccination protocol. Additional practice support materials highlighting the problems caused by Orf and its control with Scabivax Forte are also available.
The Starter Pack and full range of promotional materials are available from local Intervet/Schering-Plough Account Managers or by contacting the Veterinary Support Group on 01908 685685.
The Veterinary Medicines Directorate has published the results of the distribution category review, which has recommended the re-classification of 50 products from POM-V or POM-VPS to a less restrictive distribution category.
Not all the products recommended for reclassification will be reclassified, as in some cases, the Marketing Authorisation Holder (MAH) has declined.
MAH will change the distribution category from POM-V to NFA-VPS:Advantage Spot-on Solution for dogs, cats, small cats, small dogs and pet rabbitsDuowinScalibor Protectorband for dogsTop Drop Spot-on Solution for dogs
MAH will change the distribution category from POM-V to POM-VPS:Alpha Ject 2-2Aquavac FNM Plus VaccineAquavac FurovacFurogen 2LactovacLeptavoid HNobilis CAV P4ParacoxParacox 5 oral suspensionRotavec CoronaSpirovacSuvaxyn Ery
MAH will change the distribution category from POM-VPS to AVM-GSL:Coprite
MAH will change the distribution category from POM-V to AVM-GSL:Rearguard
MAH has decided not to change the distribution category from POM-V to NFA-VPSAdvantix Spot-on Solution for dogsFleegard for dogs / cats Frontline Combo spot on for cat and dogFrontline SprayTop Drop
Those Marketing Authorisation Holders that have indicated they are content with the recommendations are required to submit a variation to change the distribution category for the products involved by 30th June 2010, and the variations will come into force at the next label reprint.
For the full report, and a complete list of the affected products, please visit the VMD website here.
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Improve International has announced that it is to launch new 'mini-modular' courses in dentistry, oncology, neurology and ultrasound for those practitioners that want to develop a more in-depth knowledge than they would gain from a one-day course without undertaking a Certificate.
The courses, which begin in the Autumn, include two days of study each month for three months, making six days of CPD in total. Ultrasound delegates study for two days each month for two months, making four days of CPD in total. Each course, with the exception of Neurology, contains a practical element.
David Babington MRCVS, Managing Director of Improve, said: "Veterinary surgeons wanting to develop specialist skills in specific areas currently have two choices - either to embark on a full-scale Certificate programme or to attend one day sessions in their area of interest. For those without the time or resource to commit to a Certificate programme but who are keen to develop their skills to a high level, attending a one-day course may not give them the expertise - or the practical experience - they seek."
He continued: "Our Mini-Modular courses aim to bridge that gap. They are high quality programmes, led by recognised international experts, and each gives a thorough grounding in the subject, specifically geared to the requirements of the small animal general practitioner. They aim to give delegates in-depth knowledge, practical experience and the confidence to take their new skills back into practice."
The Mini-Modular courses are open to veterinary surgeons from across Europe with teaching based at Improve's training headquarters in Swindon, which offer wet-lab facilities.
For further information, visit www.improveinternational.com or call 01793 759159.
The International Veterinary Epilepsy Task Force (IVETF), a group of 26 veterinary practitioner, neuropharmacology, neuropathology and neurology experts led by Holger Volk, Professor of Veterinary Neurology and Neurosurgery at the RVC, has issued new guidelines for treating and caring for dogs with epilepsy.
The guidelines have been adopted by the American College of Veterinary Internal Medicine (ACVIM) and published in the form of a ‘consensus statement’ in the Journal of Veterinary Internal Medicine (JVIM).
Professor Volk, who co-chaired the consensus statement process, said: "I was honoured to have been asked to co-chair such an important forum in American veterinary practice. This will be another landmark paper to help improve the care vets deliver for the patients with epilepsy, both in America and beyond.
"Epilepsy is one of the most common neurological diseases encountered by veterinary surgeons and practitioners around the world. The prevalence of the condition means there have been numerous research studies carried out over the years. But, despite such frequent research, there has been a lack of consistency when it comes to diagnosis and treatment.
"This lack of cohesion and collaboration made it difficult for owners and veterinary professionals to communicate effectively on the issue of pet epilepsy. This has led to the global veterinary community changing its approach and, in recent years, working more closely together."
Professor Volk says the aim of these latest guidelines is to provide joined up and collaborative thinking, teaching and learning on various different aspects of the condition that specifically affect America. These include the development of treatment strategies and any potential issues with chronic anti-epileptic drug treatment.
The ACVIM guidelines follow on from seven in-depth consensus statements produced by the IVETF and published open access in BMC Veterinary Research last year, outlining recommendations and classifications on all aspects of canine epilepsy. It was the first time this many veterinary neurology clinicians and neuroscientists formally agreed on the key aspects of the condition.
Professor Volk, who is also the Clinical Director of the RVC’s Small Animal Referral Hospital, added: "There is a real exciting buzz around canine and feline Epilepsy currently. Finally getting to global consensus from the international veterinary community will accelerate research and lead to improved patient care and quality of life for owners and patients alike."
RCVS Knowledge says it first identified the need for an open access and easily accessible means of distributing veterinary evidence in early 2014. The concept for a new digital journal was announced at the 2014 EBVM Network Conference, and began with the mission statement of improving front-line clinical standards, funded initially by a donation from the RCVS.
In its first year Veterinary Evidence has published 58 papers which have been downloaded over 34,000 times by an international audience spanning 20 countries. It has also streamlined its submission process and added a range of new tools and resources. The tools include a downloadable submission template and a range of checklists and guidelines to help the practitioner conduct evidence-based medicine.
Looking to the future, the charity says that its website platform will be overhauled later in 2017, so practitioners can find articles quickly and implement their findings in practice.
RCVS Knowledge is now running a survey to find out what topics you'd like to see covered by Veterinary Evidence. All participants will entered into a draw for a new iPad.
Veterinary Evidence is also on the hunt for a new Editor-in-Chief, to move the journal into its next chapter. The Editor-in-Chief will have a passion for EBVM and engaging with the veterinary community and will help provide readers with the content they need. If you’re interested in applying for this role you can view the full job description here.
Researchers at the University of Edinburgh’s Royal (Dick) School of Veterinary Studies are to start testing whether a compound of cooling chemicals, extracted from mint, can be used to treat laminitis, a condition which affects seven per cent of the British horse population.
The new project, funded by The Horse Trust and led by Professor Sue Fleetwood-Walker, builds on recent work that revealed for the first time that, there is significant nerve damage, as well as inflammation, within the hoof of laminitic horses. This explains why anti-inflammatory drugs are so ineffective in treating the pain of chronic laminitis and highlights the need for therapies to treat nerve injury-induced or ‘neuropathic’ pain in horses.
Prof Fleetwood-Walker’s team discovered in 2006 that the ‘mint’ chemicals have a pain–killing effect in laboratory studies of chronic pain. They will now investigate whether this synthetic treatment could help horses with laminitis.
Petplan has been named the UK's Best Pet Insurance Provider at the Consumer Moneyfacts awards.
Voted for by over 17,000 consumers, the awards recognise the best financial products available to consumers in the UK.
Petplan, which says it has recently strengthened its policies to provide pet owners with more comprehensive cover, was chosen by consumers for its market leading policies and outstanding customer service.
Petplan Director Neil Brettell said: "The award is great recognition for the fantastic job that our team at Petplan does to keep pets healthy and owners happy.
"Our Covered for Life policies truly do what they say, they ensure that a pet can get the best possible treatment throughout its life without the owner having to worry about the cost. It's great to be recognised for the service that we've been providing to the nation's pets for over 35 years."
For information about how working with Petplan can help your practice call Vetline on 0800 316 8800 or visit www.petplanvet.co.uk
Freda Andrews, the Director of Education at the RCVS, has announced her retirement from the position on 2nd April after nearly 16 years at the College.
Freda joined the RCVS as Head of Education in September 1999 and became Director of Education in 2013, with strategic responsibility for both veterinary and veterinary nursing education.
Nick Stace, RCVS Chief Executive Officer, said: "We will miss Freda for her professionalism, her encyclopaedic knowledge of all things related to veterinary education and her attention to detail, but she leaves behind a team that is stronger-than-ever and a considerable legacy for the profession as a whole.
"Under her watch the Education Department has seen a significant number of achievements. This includes the introduction of the Professional Development Phase which has helped veterinary graduates develop their confidence and competence during the first few years of practice and the accreditation of the University of Nottingham's School of Veterinary Medicine and Science - the first new UK vet school in 50 years."
Freda's responsibilities as Director of Education will now be split between Christine Warman, Head of Education, and Julie Dugmore, Head of Veterinary Nursing.
Freda said: "I have really enjoyed working with such a fascinating profession and I think that through working very closely with our colleagues in the vet schools, as well as with practising vets, veterinary education has made some significant advances. For example, there is more focus now on communication and professional skills and greater alignment of accreditation standards internationally, to name but two things.
"I am sad to leave but I know that the future of veterinary and veterinary nursing education has been left in the very safe hands of Christine and Julie and their respective teams."
The company is now asking farm vets to point their clients in the direction of the FarmComm study and encourage them to take part, share their thoughts and help shape the way we all work together in the future.
Mat Yarnall, senior brand manager at Boehringer said: "With routine visits, practice meetings, herd or flock health planning sessions and farming shows and exhibitions all on-hold, how vets work with their clients is subject to change on a scale never seen before.
“The study is striving to understand what methods of working going forward may work, what won’t work and how people want to work.”
The FarmComm study will be being sent out directly to farmers or can be accessed at https://bit.ly/farm-comm.
Matt added: "Following analysis and interpretation, these findings will be shared with vets as we all move together into new and different times."
The researchers hope that the study will help to increase a veterinary surgeon’s index of suspicion of a particular liver disease, particularly if a biopsy-confirmed diagnosis is not possible.
In the study titled “Histopathological frequency of canine hepatobiliary disease in the United Kingdom”, histopathology reports from canine liver tissues submitted to a commercial veterinary laboratory by UK first and second opinion practices were retrospectively reviewed.
Data collected included breed, age, sex, gross and histological descriptions, diagnosis and additional comments.
Data were then grouped into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases using the four main morphological groups of vascular, biliary, parenchymal and neoplastic disorders. Breed analysis was then performed on the top five ranking breeds within each individual category.
A total of 4584 histopathology reports of canine liver tissue were included in the analysis.
The most common histopathological diagnoses were reactive hepatitis (16.8%), chronic hepatitis (16.0%) and reversible hepatocellular injury (RHI) (12.9%).
Labrador retrievers were found to have increased odds for reactive hepatitis (OR 1.57, 95%CI 1.23-1.99), whilst crossbreeds demonstrated reduced odds (OR 0.65, 95%CI 0.54-0.79).
Breeds with increased odds of chronic hepatitis included the Labrador retriever (OR 4.14, 95%CI 3.47-4.93), springer spaniel (OR 6.30, 95%CI 5.10-7.79), cocker spaniel (OR 2.78 95%CI 2.20-3.53) and West Highland White Terrier (OR 3.23, 95%CI 2.24-4.65).
Within the RHI group, the schnauzer (OR 8.06, 95%CI 5.77-11.26) and Bichon Frise (OR 5.19, 95%CI 3.63-7.42) had increased odds of disease.
Dr Yuvani Bandara, corresponding author for the paper, said: “This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK.
“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predispositions.”
The full article can be found in the September issue of the Journal of Small Animal Practice and can be read online here: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13354.
Reference
VetCell is celebrating a win at Cheltenham, after 'Knowhere' won the Cotswold Chase following pioneering stem cell treatment for a serious tendon injury.
Knowhere had had a good start to his racing career as a four-year-old, winning his first two races as a novice hurdler. But after his second race in 2004 he suffered injuries to both forelimb superficial digital flexor tendons. The left fore showed low grade tendonitis while the right fore had a significant percentage of fibre rupture. As a promising racing prospect, Knowhere’s connections wanted to give him the best possible chance of recovering from his injury so they opted for stem cell therapy. He was treated by Tim Beauregard MRCVS of Summerhill Farm in Gloucestershire.
Bone marrow samples were collected from Knowhere’s sternum and were processed in VetCell's laboratory over a five week period to generate millions of stem cells. Knowhere was sedated, the tendon area was anaesthetised and the leg was then surgically clipped and disinfected. Stem cells, which had been suspended in serum obtained from the original bone marrow sample, were then injected using ultrasound guidance, into the core of the damaged area of the tendon fibres.
For the first week after the implantation Knowhere was kept in his stable to allow the cells to adapt to their new environment. Each day after this he was given walking exercise in order to stimulate the activity of the stem cells, encouraging them to differentiate into tendon cells and form into strong tendon fibres. The amount of exercise was incrementally increased, building up over a three-month period from five minutes each day to 45 minutes twice a day.
By the autumn of 2005 both of Knowhere’s tendons had healed very well and showed good fibre pattern on ultrasonography. He was re-introduced to the racetrack the following year and of the 15 or so races he has been in since, he has finished in the frame on eight occasions and has amassed some £175,000 in winnings.
Vet Tim Beauregard said: “Knowhere’s successful return to the track has been exciting and immensely satisfying to follow and he showed particularly brilliant form in the Cotswold Chase. It remains to be seen whether he will be heading for the Ryanair Chase, the Gold Cup or the Grand National but all involved will be hoping for the best.”
For more information please contact VetCell on +44 207 691 2062 or 866 764 0340, email: info@vetcell.com or visit the website at http://www.vetcell.com/
Vet Futures, the joint initiative by the RCVS and the BVA to help the profession prepare for and shape its own future, has revealed the results of a survey which found that 59% of veterinary surgeons are optimistic about the future of the profession. 600 vets took part in the survey, which explored vets' attitudes towards their profession, and asked them to prioritise the key issues and rank some of the major threats and opportunities for the profession.Reducing stress was the single most important goal for the future, with 19% of respondents choosing it from a long list of options.The BVA and the RCVS say that priority goals for veterinary surgeons varied according to different areas of work and seniority in the profession. However, an overriding and uniting theme from the findings was the pursuit of recognition for the role vets play across the board. Vets' perception of the veterinary contribution to non-clinical roles, such as research, food supply and security, and public health, is high, but they don't believe the general public values these roles.Four of the respondents' top five goals for 2030 related to recognition:
Looking at how vets are respected and valued by society, Vet Futures points to its national ICM opinion poll of more than 2,000 members of the public which found that 94% of the general public trusts the veterinary profession generally or completely.
In terms of their own careers, 59% of vets said they felt that they had met or exceeded their expectations, leaving 41% saying their careers had only met some expectations (38%) or not met any (3%). Amongst this large minority of dissatisfied vets the reasons for their responses included: few opportunities for progression, pay, and working hours.The survey also asked vets to rank threats and opportunities for the profession and found that respondents considered the three greatest opportunities to be:
BVA President John Blackwell said: "It's heartening to see that, at the moment, the veterinary glass is half full for many. But we know that younger vets are disproportionately represented amongst those who are feeling less positive about their own careers, which is a real concern for future generations. There is clearly work to be done, through Vet Futures, for the profession to think innovatively in order to tackle some of their concerns around career progression, pay and working hours, as well as stress."The good news is that, through the Vet Futures UK-wide roadshow and our online engagement, we have been hearing new and interesting ideas for the future. We want to hear from as many vets, vet nurses and others who have a stake in the future of the profession and I would encourage people to get involved through our 'Veterinary Vision' essay competition or via the Vet Futures website."RCVS President Stuart Reid added: "There is a lot for the veterinary profession to be proud of but the Vet Futures survey shows that vets are concerned the general public doesn't understand or value the variety of roles we undertake outside clinical practice."We have also heard through our guest blog that vets working outside of practice sometimes feel that they are treated as second-class vets. "Through the Vet Futures project RCVS and BVA aim to address the lack of public awareness about the variety of roles undertaken by members of the profession, as well as increase understanding and access to these varied career opportunities amongst the profession. "We want to enable all veterinary surgeons to not only feel optimistic, but confident in their future."
At the start of June, the British Veterinary Association (BVA), British Cattle Veterinary Association (BCVA), Goat Veterinary Society (GVS), and Sheep Veterinary Society (SVS) welcomed the announcement that bluetongue (BTV-8) vaccine would be available by mid-July to support farmers and smallholders in managing the risk of a bluetongue outbreak predicted to reach mainland UK by late summer.
Since the Defra risk assessment indicates a high risk by late summer of a BTV incursion from France, veterinary associations have been involved in discussions with government, farmers’ representatives and manufacturers to ensure vaccine is available to meet potential demand particularly in the south of England where risk is highest. The situation remains under constant review by Defra as the disease develops and the weather warms up, promoting midge activity.
Pharmaceutical companies MSD and Zoetis announced that batches of vaccine would be available from mid-July, which Defra has just confirmed.
Vets across the UK are also contributing to the Joint campaign Against Bluetongue (JAB), helping to make farmers aware of the risk, clinical signs and what action to take, through speaking at local JAB information events and displaying posters and leaflets in practices.
While welcoming the announcement of vaccine availability in June, veterinary organisations also sought clarification about the cost and the amount of vaccine likely to be available in July and thereafter. This information is now available.
BVA President Sean Wensley said: "We welcome the announcement that vaccine will be available in time to meet potential demand. This disease seriously affects animal health and welfare as well as the productivity of livestock, and vaccination is the key control."
Photo by Fourrure (http://www.boulesdefourrure.fr) [CC BY-SA 2.0], via Wikimedia Commons
Amanda originally studied and worked in Australia where she undertook a residency in small animal medicine at Murdoch University, completing a Masters in respiratory medicine in dogs.
She moved to the UK in 2016 to work in referral medicine, joining Hamilton Specialist Referrals in 2024 as head of its medicine service.
The webinar will include a refresher on the bacterial, fungal, parasitic and protozoal causes of lower respiratory tract disease and its pathology, after which it will look at techniques and methods for diagnosis.
Amanda's presentation will also look at the secondary effects of infectious lower respiratory disease pathogens, and prescribing and management options.
https://horiba.link/respiratory-disease-in-dogs-and-cats
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Fort Dodge Animal Health has announced it is working with the authorities to put measures in place to make its West Nile Virus vaccine, licensed in the United States, available to the European equine market. These measures will ensure a vaccine is readily available in the event of an outbreak in the UK.
This news comes as the Zooprophylactic Institute of Teramo, the Italian National Reference Centre for Exotic Diseases, has confirmed an outbreak of WNV among horses in stables in the northern province of Ferrara. About 20 horses are believed to have been affected.
Fort Dodge was the first company to develop and fully license a vaccine to protect horses against this potentially deadly disease. An inactivated whole virus vaccine, it was the only vaccine available in the United States at the height of the 2002 outbreak, which affected 15,000 horses. The U.S. Department of Agriculture credited the vaccine with contributing to the 70 per cent decline in U.S. equine West Nile cases since the height of the outbreak. WNV is now considered endemic in all areas of North America.
"As this latest outbreak of WNV in Italy highlights, the disease presents an increasing threat to the equestrian sector in Europe," says Helen Barnes, EMEA Equine Business Manager for Fort Dodge. "With little current natural immunity among the equine population, the consequences of a major outbreak could be devastating."
"Until now, horse owners in Europe have perhaps believed WNV is not a disease they should be concerned with but the outbreak in Ferrara came out of the blue, and at a time when a human case of WNV was also reported in the same province. This situation of both human and equine cases being reported is identical to that seen in the outbreaks in the United States. It's a stark reminder of the challenge this disease poses, particularly as environmental factors, such as global warming and heavy rains threaten to create mass breeding grounds for mosquitoes," says Barnes.
"Our experience with WNV in the United States has given us an exceptional understanding of the disease and the importance of vaccination. We now look forward to working in partnership with the European governments, the EU Commission and the veterinary community across Europe to help build understanding and knowledge of this dangerous emerging disease threat."
Siemens will be showcasing its range of technology for veterinary care, from advanced ultrasound, CT and MRI systems to haematological and immunological diagnostics at BSAVA Congress.
The company says MRI and CT are starting to become more influential in the veterinary field. MRI provides a reliable veterinary imaging method when traditional procedures such as X-ray and ultrasound are not able to convey the detail needed. They display small changes in bone and soft tissue and can be complemented with special adjustments such as mini coils for dog and cat paws to make them suitable for application with animals. This allows vets to diagnose more accurately and treat specific complaints. The images produced by MRI systems can be used for tumour diagnosis, nervous complaints or orthopaedic problems as well as intestinal, respiratory or cardiovascular disorders.
Siemens will also be presenting its in vitro range of solutions and assays in chemistry, haematology and immunology.
This will include the IMMULITE® range, a blood testing platform which the company says has an unrivalled immunoassay portfolio, allowing the rapid diagnosis of a broad spectrum of small animal conditions.
Information on the ADVIA® 2120i Haematology System with specific animal software and Dimension® Xpand® Plus integrated chemistry and immunoassay system will also be available.
Product literature and in-depth discussions with Siemens specialists will be available from the stand during the event.
Quantum Vet Diagnostics (a division of Woodley Equipment Co Ltd) has announced the launch of a new wet chemistry analyser.
The Quantum Saturno is offered exclusively by Quantum with a total maintenance and reagent package. One fixed monthly payment provides all standard reagents for a month, control solution, monthly maintenance visits by an experienced technician, all parts, consumables, repairs and support from a dedicated wet chemistry division. There are also a wide range of special chemistry tests available.
Quantum says the key features of the new analyser are:
For more details contact 01798 813659 or email: sales@quantumvetdiagnostics.com
Denise Coston of Castle Veterinary Surgeons in Durham has won The Veterinary Business Journal Practice Manager of the Year 2011, and praised the award for promoting her role.
Denise, who was a manager at Lloyds TSB's lending centre and previously ran her own business, before joining Castle Vets three years ago, said: "I did not find out that I had been nominated until three weeks before the ceremony - it was totally out of the blue. To make it to the final three was brilliant, but to win was just incredible.
Denise also said the Practice Manager of the Year Award plays a vital part in promoting the role of practice managers to the wider industry: "It is so important in recognising and championing the efforts of practice managers. I'm sure there will be many people out there who still don't know what we do or how we could benefit their business and this award highlights our achievements.
"This is an evolving role and it is often a case of matching what each practice needs, but I think the fact that there is an award highlights the point that there is true value in having a practice manager."
Editor of The Veterinary Business Journal Robin Fearon said: "Denise is a deserving winner of the title Practice Manager of the Year because she understands the importance of helping to define business strategy for the practice, and I wish her every success in future."